iSpecimen Inc.
ISPC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8 | $2 | $1 | $2 |
| - Cash | $3 | $1 | $1 | $2 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $2 | $0 | $0 |
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -85.1% | -32.6% | -28.3% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -91.9% | 37.7% | 37.8% | 10.3% |
| EBITDA | -$2 | -$1 | -$1 | -$5 |
| % Margin | -2,211.4% | -86.2% | -114% | -358.9% |
| Net Income | -$3 | -$1 | -$2 | -$6 |
| % Margin | -2,608.7% | -146.9% | -156.8% | -409.8% |
| EPS Diluted | -0.48 | -0.42 | -2.33 | -8.51 |
| % Growth | -14.3% | 82% | 72.6% | – |
| Operating Cash Flow | -$2 | -$0 | -$1 | -$3 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$2 | -$0 | -$1 | -$3 |